Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma-Reference-Cited by-同舟云学术

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma

Published:2010-06-06 Issue:7 Volume:16 Page:793-798
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Palanisamy Nallasivam,Ateeq Bushra,Kalyana-Sundaram Shanker,Pflueger Dorothee,Ramnarayanan Kalpana,Shankar Sunita,Han Bo,Cao Qi,Cao Xuhong,Suleman Khalid,Kumar-Sinha Chandan,Dhanasekaran Saravana M,Chen Ying-bei,Esgueva Raquel,Banerjee Samprit,LaFargue Christopher J,Siddiqui Javed,Demichelis Francesca,Moeller Peter,Bismar Tarek A,Kuefer Rainer,Fullen Douglas R,Johnson Timothy M,Greenson Joel K,Giordano Thomas J,Tan Patrick,Tomlins Scott A,Varambally Sooryanarayana,Rubin Mark A,Maher Christopher A,Chinnaiyan Arul M

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2166.pdf

Reference32 articles.

1. Soda, M. et al. Identification of the transforming EML4-ALK fusion gene in non–small-cell lung cancer. Nature 448, 561–566 (2007).

2. Tomlins, S.A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644–648 (2005).

3. Kumar-Sinha, C., Tomlins, S.A. & Chinnaiyan, A.M. Recurrent gene fusions in prostate cancer. Nat. Rev. Cancer 8, 497–511 (2008).

4. Koivunen, J.P. et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin. Cancer Res. 14, 4275–4283 (2008).

5. Maher, C.A. et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc. Natl. Acad. Sci. USA 106, 12353–12358 (2009).

Cited by 412 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histopathologic, genomic, transcriptomic, and functional characteristics of eight melanocytic tumors with BRAF fusions showing stronger MAPK pathway activation compared to BRAF V600E tumors;Journal of Cutaneous Pathology;2024-08-22

2. Recent nanotechnological aspects and molecular targeting strategies for lung cancer therapy;Journal of Nanoparticle Research;2024-05

3. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors;The Journal of Pathology;2024-04-17

4. Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations;Neoplasia;2024-04

5. The role of CRAF in cancer progression: from molecular mechanisms to precision therapies;Nature Reviews Cancer;2024-01-09